Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was SEK 18.89 million compared to SEK 13.29 million a year ago. Revenue was SEK 19.05 million compared to SEK 13.94 million a year ago. Net loss was SEK 5.82 million compared to SEK 7.65 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.1 a year ago.